Elicio Therapeutics, Inc.

Direct answer

Elicio Therapeutics, Inc. is publicly traded on NASDAQ under the ticker ELTX.

Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG adjuvant that forms...

Can you invest in Elicio Therapeutics, Inc.?

Yes. Elicio Therapeutics, Inc. is publicly traded on NASDAQ under the ticker ELTX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Elicio Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.